Gennex Laboratories Ltd

Gennex Laboratories Ltd

₹ 18.0 6.70%
21 May - close price
About

Incorporated in 1995, Gennex Laboratories Ltd manufactures Bulk Drugs and Intermediaries[1]

Key Points

Business Overview:[1][2]
GLL is an ISO 9001:2008, TUV, ISO 14001 and OSHAS 18000 certified vertically integrated Active Pharmaceutical Ingredient manufacturer & exporter of Bulk Drugs, Intermediates and Biotech Products in the form of Expectorants,
Muscle Relaxants, Analgesic and Anti Fungal, etc.

  • Market Cap 409 Cr.
  • Current Price 18.0
  • High / Low 21.9 / 6.12
  • Stock P/E 42.9
  • Book Value 4.77
  • Dividend Yield 0.00 %
  • ROCE 10.7 %
  • ROE 7.35 %
  • Face Value 1.00

Pros

  • Company has reduced debt.
  • Company is almost debt free.
  • Company has delivered good profit growth of 40.4% CAGR over last 5 years

Cons

  • Stock is trading at 3.78 times its book value
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Promoter holding has decreased over last quarter: -5.18%
  • The company has delivered a poor sales growth of 8.26% over past five years.
  • Promoter holding is low: 18.4%
  • Company has a low return on equity of 9.03% over last 3 years.
  • Earnings include an other income of Rs.3.92 Cr.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
15.45 16.21 10.40 14.29 16.69 20.18 13.94 19.62 13.90 18.15 14.14 14.24 17.08
13.69 13.65 8.75 12.34 15.36 19.40 13.06 17.77 12.81 16.88 10.22 10.27 15.64
Operating Profit 1.76 2.56 1.65 1.95 1.33 0.78 0.88 1.85 1.09 1.27 3.92 3.97 1.44
OPM % 11.39% 15.79% 15.87% 13.65% 7.97% 3.87% 6.31% 9.43% 7.84% 7.00% 27.72% 27.88% 8.43%
0.16 0.02 0.00 0.00 0.00 1.04 0.57 0.00 0.73 1.59 0.03 0.06 2.24
Interest 0.14 0.21 0.15 0.24 0.14 0.34 0.18 0.36 0.18 0.51 0.30 0.28 0.32
Depreciation 0.22 0.22 0.20 0.20 0.19 0.20 0.26 0.10 0.19 0.20 0.20 0.20 0.20
Profit before tax 1.56 2.15 1.30 1.51 1.00 1.28 1.01 1.39 1.45 2.15 3.45 3.55 3.16
Tax % 21.15% 8.84% 26.92% 26.49% 21.00% 16.41% 24.75% 25.18% 24.83% 22.33% 25.22% 25.07% 16.46%
1.23 1.95 0.95 1.11 0.79 1.07 0.75 1.05 1.08 1.67 2.57 2.66 2.64
EPS in Rs 0.06 0.10 0.05 0.06 0.04 0.06 0.04 0.06 0.07 0.09 0.15 0.15 0.15
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
24.56 29.93 34.99 31.90 38.52 41.89 43.78 55.75 55.55 59.65 61.21 65.10 63.61
22.94 28.40 33.36 29.88 34.32 37.36 41.58 51.73 52.31 53.12 55.83 60.51 53.01
Operating Profit 1.62 1.53 1.63 2.02 4.20 4.53 2.20 4.02 3.24 6.53 5.38 4.59 10.60
OPM % 6.60% 5.11% 4.66% 6.33% 10.90% 10.81% 5.03% 7.21% 5.83% 10.95% 8.79% 7.05% 16.66%
0.08 0.02 0.21 0.19 0.17 0.12 0.91 0.78 1.06 0.15 1.38 3.40 3.92
Interest 0.30 0.28 0.32 0.48 0.50 0.71 0.73 0.79 0.75 0.74 0.88 1.23 1.41
Depreciation 0.74 0.80 0.82 0.89 0.84 0.84 0.92 0.98 1.00 0.88 0.79 0.74 0.80
Profit before tax 0.66 0.47 0.70 0.84 3.03 3.10 1.46 3.03 2.55 5.06 5.09 6.02 12.31
Tax % 42.42% 17.02% 70.00% 22.62% 22.77% 12.90% 42.47% 26.40% 27.06% 20.16% 22.99% 24.09%
0.38 0.40 0.21 0.65 2.34 2.70 0.84 2.22 1.86 4.04 3.92 4.56 9.54
EPS in Rs 0.02 0.02 0.01 0.03 0.12 0.14 0.04 0.12 0.10 0.21 0.21 0.26 0.54
Dividend Payout % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: 8%
5 Years: 8%
3 Years: 5%
TTM: -6%
Compounded Profit Growth
10 Years: 27%
5 Years: 40%
3 Years: 36%
TTM: 142%
Stock Price CAGR
10 Years: 34%
5 Years: 41%
3 Years: 43%
1 Year: 169%
Return on Equity
10 Years: 7%
5 Years: 8%
3 Years: 9%
Last Year: 7%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Sep 2023
Equity Capital 12.65 12.65 12.65 12.65 12.65 12.65 12.65 12.65 12.65 12.65 12.65 18.02 17.98
Reserves 12.13 12.53 12.74 12.88 15.59 18.29 19.13 21.35 23.20 27.24 31.35 61.00 66.63
1.90 2.41 3.19 3.84 2.43 3.84 2.47 4.54 4.98 7.36 10.12 0.98 3.54
7.70 8.76 11.01 9.84 11.12 14.43 16.22 13.37 16.29 11.83 14.09 16.22 16.21
Total Liabilities 34.38 36.35 39.59 39.21 41.79 49.21 50.47 51.91 57.12 59.08 68.21 96.22 104.36
16.19 15.97 16.11 14.70 15.46 15.51 15.58 15.64 14.93 14.13 13.70 15.18 14.84
CWIP 0.00 0.00 0.00 0.00 0.12 0.23 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Investments 7.01 7.01 7.01 7.01 7.01 7.01 7.01 7.01 7.01 7.01 7.01 8.26 8.26
11.18 13.37 16.47 17.50 19.20 26.46 27.88 29.26 35.18 37.94 47.50 72.78 81.26
Total Assets 34.38 36.35 39.59 39.21 41.79 49.21 50.47 51.91 57.12 59.08 68.21 96.22 104.36

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
2.12 -1.73 0.48 0.21 3.35 -0.11 3.16 1.88 -1.67 -1.44 6.64 -14.45
-0.85 -0.57 -0.90 -0.20 -1.15 -0.97 -0.67 -0.99 -0.22 -0.02 -1.26 -0.77
0.05 0.23 0.45 0.18 -1.92 0.86 -2.10 1.25 -0.35 1.62 1.87 21.35
Net Cash Flow 1.32 -2.07 0.03 0.19 0.29 -0.22 0.39 2.13 -2.23 0.16 7.24 6.14

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Debtor Days 45.18 48.90 50.59 70.83 65.95 89.75 87.21 68.09 41.26 54.77 67.44 49.45
Inventory Days 49.55 33.72 28.81 22.75 47.42 42.59 30.91 57.35 78.28 49.91 71.85 132.82
Days Payable 99.55 103.09 117.38 120.89 113.55 139.40 160.77 87.81 85.65 59.06 71.85 57.58
Cash Conversion Cycle -4.82 -20.46 -37.98 -27.32 -0.18 -7.07 -42.65 37.64 33.90 45.62 67.44 124.69
Working Capital Days 24.67 55.49 64.68 87.99 75.52 106.48 92.54 86.03 119.45 152.61 147.77 239.86
ROCE % 3.65% 2.84% 3.63% 4.56% 11.89% 11.64% 6.32% 10.50% 8.04% 14.01% 11.78% 10.74%

Shareholding Pattern

Numbers in percentages

4 Recently
Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
22.05% 22.05% 22.05% 22.05% 22.05% 23.38% 23.38% 23.38% 23.38% 23.61% 23.61% 18.41%
77.95% 77.95% 77.95% 77.95% 77.95% 76.63% 76.62% 76.62% 76.62% 76.39% 76.39% 81.58%
No. of Shareholders 36,24346,38050,05256,68957,87759,17258,24855,60952,98150,98869,72383,996

Documents